Esperion Therapeutics
ESPR
ESPR
148 hedge funds and large institutions have $426M invested in Esperion Therapeutics in 2022 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 59 increasing their positions, 41 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 136 → 148 (+12)
7.35% more ownership
Funds ownership: 87.8% → 95.15% (+7.3%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
148
Holding in Top 10
2
Calls
$22.5M
Puts
$4.14M
Top Buyers
| 1 | +$11.8M | |
| 2 | +$7.35M | |
| 3 | +$5.38M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$5.1M |
| 5 |
Two Sigma Investments
New York
|
+$4.71M |
Top Sellers
| 1 | -$6.75M | |
| 2 | -$3.45M | |
| 3 | -$3.29M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$2.5M |
| 5 |
D.E. Shaw & Co
New York
|
-$2.42M |